PEARL: A Multicenter Phase 2 Study of Lorlatinib in Patients with ALK-rearranged NSCLC and Central Nervous System Disease
Clinical Lung Cancer(2024)
Key words
Non-small cell lung cancer,ALK fusion,CNS metastases,ALK TKI
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined